Global Thrombin Market Growth 2024-2030

Publication ID:

LPI03248587

Publication Date:

March 11, 2024

Pages:

118

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Thrombin market size was valued at US$ 552.7 million in 2023. With growing demand in downstream market, the Thrombin is forecast to a readjusted size of US$ 692.2 million by 2030 with a CAGR of 3.3% during review period.
The research report highlights the growth potential of the global Thrombin market. Thrombin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Thrombin. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Thrombin market.
Thrombin听is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
Key Features:
The report on Thrombin market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Thrombin market. It may include historical data, market segmentation by Type (e.g., Powder Form, Solution Form), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Thrombin market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Thrombin market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Thrombin industry. This include advancements in Thrombin technology, Thrombin new entrants, Thrombin new investment, and other innovations that are shaping the future of Thrombin.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Thrombin market. It includes factors influencing customer ' purchasing decisions, preferences for Thrombin product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Thrombin market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Thrombin market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Thrombin market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Thrombin industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Thrombin market.
Market Segmentation:
Thrombin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Segmentation by application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Thrombin market?
What factors are driving Thrombin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Thrombin market opportunities vary by end market size?
How does Thrombin break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thrombin Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Thrombin by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Thrombin by Country/Region, 2019, 2023 & 2030
2.2 Thrombin Segment by Type
2.2.1 Powder Form
2.2.2 Solution Form
2.2.3 Pad Form
2.2.4 Spray Kits
2.2.5 Others
2.3 Thrombin Sales by Type
2.3.1 Global Thrombin Sales Market Share by Type (2019-2024)
2.3.2 Global Thrombin Revenue and Market Share by Type (2019-2024)
2.3.3 Global Thrombin Sale Price by Type (2019-2024)
2.4 Thrombin Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics & Clinics
2.4.3 Academic and Research Institute
2.5 Thrombin Sales by Application
2.5.1 Global Thrombin Sale Market Share by Application (2019-2024)
2.5.2 Global Thrombin Revenue and Market Share by Application (2019-2024)
2.5.3 Global Thrombin Sale Price by Application (2019-2024)
3 Global Thrombin by Company
3.1 Global Thrombin Breakdown Data by Company
3.1.1 Global Thrombin Annual Sales by Company (2019-2024)
3.1.2 Global Thrombin Sales Market Share by Company (2019-2024)
3.2 Global Thrombin Annual Revenue by Company (2019-2024)
3.2.1 Global Thrombin Revenue by Company (2019-2024)
3.2.2 Global Thrombin Revenue Market Share by Company (2019-2024)
3.3 Global Thrombin Sale Price by Company
3.4 Key Manufacturers Thrombin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thrombin Product Location Distribution
3.4.2 Players Thrombin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Thrombin by Geographic Region
4.1 World Historic Thrombin Market Size by Geographic Region (2019-2024)
4.1.1 Global Thrombin Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Thrombin Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Thrombin Market Size by Country/Region (2019-2024)
4.2.1 Global Thrombin Annual Sales by Country/Region (2019-2024)
4.2.2 Global Thrombin Annual Revenue by Country/Region (2019-2024)
4.3 Americas Thrombin Sales Growth
4.4 APAC Thrombin Sales Growth
4.5 Europe Thrombin Sales Growth
4.6 Middle East & Africa Thrombin Sales Growth
5 Americas
5.1 Americas Thrombin Sales by Country
5.1.1 Americas Thrombin Sales by Country (2019-2024)
5.1.2 Americas Thrombin Revenue by Country (2019-2024)
5.2 Americas Thrombin Sales by Type
5.3 Americas Thrombin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thrombin Sales by Region
6.1.1 APAC Thrombin Sales by Region (2019-2024)
6.1.2 APAC Thrombin Revenue by Region (2019-2024)
6.2 APAC Thrombin Sales by Type
6.3 APAC Thrombin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Thrombin by Country
7.1.1 Europe Thrombin Sales by Country (2019-2024)
7.1.2 Europe Thrombin Revenue by Country (2019-2024)
7.2 Europe Thrombin Sales by Type
7.3 Europe Thrombin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Thrombin by Country
8.1.1 Middle East & Africa Thrombin Sales by Country (2019-2024)
8.1.2 Middle East & Africa Thrombin Revenue by Country (2019-2024)
8.2 Middle East & Africa Thrombin Sales by Type
8.3 Middle East & Africa Thrombin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thrombin
10.3 Manufacturing Process Analysis of Thrombin
10.4 Industry Chain Structure of Thrombin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thrombin Distributors
11.3 Thrombin Customer
12 World Forecast Review for Thrombin by Geographic Region
12.1 Global Thrombin Market Size Forecast by Region
12.1.1 Global Thrombin Forecast by Region (2025-2030)
12.1.2 Global Thrombin Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Thrombin Forecast by Type
12.7 Global Thrombin Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Thrombin Product Portfolios and Specifications
13.1.3 Takeda Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Thrombin Product Portfolios and Specifications
13.2.3 Bayer Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Thrombin Product Portfolios and Specifications
13.3.3 CSL Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Thrombin Product Portfolios and Specifications
13.4.3 Grifols Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Thrombin Product Portfolios and Specifications
13.5.3 GE Healthcare Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Hualan Biological
13.6.1 Hualan Biological Company Information
13.6.2 Hualan Biological Thrombin Product Portfolios and Specifications
13.6.3 Hualan Biological Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Biological Main Business Overview
13.6.5 Hualan Biological Latest Developments
13.7 Haematologic Technologies Inc.
13.7.1 Haematologic Technologies Inc. Company Information
13.7.2 Haematologic Technologies Inc. Thrombin Product Portfolios and Specifications
13.7.3 Haematologic Technologies Inc. Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Haematologic Technologies Inc. Main Business Overview
13.7.5 Haematologic Technologies Inc. Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Thrombin Product Portfolios and Specifications
13.8.3 Pfizer Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Octapharma
13.9.1 Octapharma Company Information
13.9.2 Octapharma Thrombin Product Portfolios and Specifications
13.9.3 Octapharma Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Octapharma Main Business Overview
13.9.5 Octapharma Latest Developments
13.10 Omrix Biopharmaceuticals Ltd.
13.10.1 Omrix Biopharmaceuticals Ltd. Company Information
13.10.2 Omrix Biopharmaceuticals Ltd. Thrombin Product Portfolios and Specifications
13.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Omrix Biopharmaceuticals Ltd. Main Business Overview
13.10.5 Omrix Biopharmaceuticals Ltd. Latest Developments
13.11 Shanghai RAAS
13.11.1 Shanghai RAAS Company Information
13.11.2 Shanghai RAAS Thrombin Product Portfolios and Specifications
13.11.3 Shanghai RAAS Thrombin Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai RAAS Main Business Overview
13.11.5 Shanghai RAAS Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂